TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmex AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
24,474
|
23,969
|
17,587 |
Financial expenses |
755
|
874
|
99 |
Earnings before taxes |
3,568
|
3,529
|
2,394 |
Total assets |
10,785
|
9,751
|
9,340 |
Current assets |
10,785
|
9,751
|
9,340 |
Current liabilities |
3,763
|
3,028
|
3,846 |
Equity capital |
6,808
|
6,426
|
5,101 |
- share capital |
593
|
635
|
616 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.1%
|
65.9%
|
54.6% |
Turnover per employee | |||
Profit as a percentage of turnover |
14.6%
|
14.7%
|
13.6% |
Return on assets (ROA) |
40.1%
|
45.2%
|
26.7% |
Current ratio |
286.6%
|
322.0%
|
242.8% |
Return on equity (ROE) |
52.4%
|
54.9%
|
46.9% |
Change turnover |
2,093
|
5,838
|
3,803 |
Change turnover % |
9%
|
32%
|
28% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.